ロード中...
P14.02 Acute ataxia secondary to capecitabine
INTRODUCTION: Capecitabine is an oral prodrug of 5-Fluorouracil (5-FU). It is metabolized to its cytotoxic form, 5-FU, by the enzyme thymidine phosphorylase and is used to treat breast and gastrointestinal adenocarcinomas. The cerebellar toxicity of 5-FU is well known, and the median time from treat...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782754/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.262 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|